Company Filing History:
Years Active: 2025
Title: Anniesha Hack: Innovator in Immunotherapy
Introduction
Anniesha Hack is a notable inventor based in East Hanover, MA (US). He has made significant contributions to the field of immunotherapy, particularly through his innovative work on chimeric antigen receptors.
Latest Patents
Anniesha holds one patent titled "Chimeric antigen receptors and uses thereof." This invention provides immune effector cells, such as T cells and NK cells, that express a chimeric antigen receptor (CAR). The patent outlines various compositions and methods for utilizing these immune cells in therapeutic applications.
Career Highlights
Anniesha Hack is currently associated with Novartis AG, a leading global healthcare company. His work focuses on advancing the field of immunotherapy, which has the potential to revolutionize cancer treatment and other diseases.
Collaborations
Some of his coworkers include Aida Abujoub and John Blankenship, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Anniesha Hack's innovative work in the development of chimeric antigen receptors showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic strategies in immunotherapy.